U-Blot® Research Grade Anti-Human CD371/CLEC12A Antibody (H6e7)Cat. No. WA1672Request quote
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade Anti-Human CD371/CLEC12A Antibody (H6e7)Cat. No. WA1672
U-Blot® Research Grade Anti-Human CD371/CLEC12A (DCLL9718S)Cat. No. WA1671
U-Blot® Research Grade Anti-Human CD37/TSPAN26 (BI 836826)Cat. No. WA1670
U-Blot® Research Grade Anti-Human CD37/TSPAN26 (AGS67E)Cat. No. WA1669
U-Blot® Research Grade Anti-Human CD366/HAVCR2/TIM-3 (TQB2618)Cat. No. WA1668
U-Blot® Research Grade Anti-Human CD366/HAVCR2/TIM-3 (Sym023)Cat. No. WA1667
U-Blot® Research Grade Anti-Human CD366/HAVCR2/TIM-3 (LY3321367)Cat. No. WA1666
U-Blot® Research Grade Anti-Human CD366/HAVCR2/TIM-3 (KL-293)Cat. No. WA1665
U-Blot® Research Grade Anti-Human CD366/HAVCR2/TIM-3 (INCAGN02390)Cat. No. WA1664
U-Blot® Research Grade Anti-Human CD366/HAVCR2/TIM-3 (ES001)Cat. No. WA1663
U-Blot® Research Grade Anti-Human CD365/KIM-1/TIM-1/HAVCR1 (CDX 014)Cat. No. WA1662
U-Blot® Research Grade Anti-Human CD360/IL21R (ATR-107)Cat. No. WA1661